Things are clicking hard across the U planet from U companies/producers to brokers to utilities to investors to funds to etc
I'm not much to be overly optimistic and rely on more of a realist attitude, however, the U spot high in the $140's surely is in play sometime during 2024 if things regarding U maintain this enthusiasm (a bit of consolidation would be good along the way to cement the gains)
When I compare DYL to BMN and BMN's MC effectively being half of DYL (yes some of DYL's MC is tied to Australian assets in WA and NT but funnily enough for Australia I also see those assets in WA and NT as a Sovereign risk) yet they are both looking at similar timelines to production, production rates, enormous resources to ramp up annual production, etc, yet BMN's CAPEX is ~USD$100m less in Namibia ... it reads well for BMN IMO
If BMN sticks to the timelines regarding offtake and financing you would have to say the BMN high from 2/3 years ago is in play during 2024
- Forums
- ASX - By Stock
- BMN
- Bannerman Poised to Break Out
Bannerman Poised to Break Out, page-358
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BMN (ASX) to my watchlist
|
|||||
Last
$3.20 |
Change
0.000(0.00%) |
Mkt cap ! $562.4M |
Open | High | Low | Value | Volume |
$3.21 | $3.23 | $3.10 | $1.840M | 581.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 799 | $3.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.20 | 4698 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 799 | 3.170 |
1 | 14000 | 3.140 |
1 | 2000 | 3.130 |
1 | 3250 | 3.110 |
9 | 27728 | 3.100 |
Price($) | Vol. | No. |
---|---|---|
3.200 | 4698 | 2 |
3.220 | 5000 | 1 |
3.250 | 1983 | 1 |
3.270 | 7000 | 2 |
3.300 | 12040 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BMN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online